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J 1029-1513 Coronary Stentlng In Acute Myo.rdlal 
Infarction With Cardlogenl© Shock 
1", Lefevm, M,-C. Mort~, G, Kamllon, M, Krol, Y. Louvem, P, Ouma~, 
B, Abry, J,F, Angellmr, J,.K V~etaira, ICPS, M~$sy, Franc~ 
Back~*  C4z~+ .t~q~. llllOCk In ar, utO MI is us~)¢ial~i ~th a high mort~ity 
rate even after suco)~ful PTCA. 
M#l~hod~: The pgq~0~ of this Sh~ w~ to evaluate th~ lo f lg~ of 
OXlmlziN~ mm of ¢+~m~my M0fltmg (=nag 01/95) in ~ tmfling~ 
R#m,r/~' Ot+1 of 393 AMI pl$ odm~ttod within 12 ho~r~ atl~r th0 onset 
of MI, Sl (t2,G%) ~ in ¢~rd~gm~ ehod~ Me~t ~o w~ 70 ~: 13 ym 
(31% f~m~k~), MI wa~ I~blft~, in ~% of r ,~¢ IRA was LAD in §t%, loft 
n~in t§%, RC.~ 2S% ~d Ci¢ in t~ Of ¢~.  Procedural 5ucc~s was 
Obteu!~ in 00% of ~ (~tOmtt: 71PPe, proced~Jr+ll eiur.~ess; 97%) with 34 
t0 m door tO litlmt ~ TI~ in , l~ l  ,J:o~n~ was; t (~+) ft~4~t PTCA 
to nd!~ (~4 hours; 22% w ~,4 ho~ 62%_. p ~ 0,069) P.nd by a i~i~ng 
I~, wt4h _1~ !~1 t19-'~:,~) 19110+t%) 19 (I~.P,,) 
~t~l  ~ (%) ~3~ 695 73.7 
~ (%1 033 89 5 944 
I[~k~t~ s=tera (m~n) 40 ~ ~.JZ 3~: 10 29± +;~ 
tn -~ dmt, m f%) 5~ 5 57.9 43.4 
C ~ :  C,~o~_ I~b~tlm~ m AMI wttkt cae~f t i c  shock is as_ ~la.tecJ 
a high pm¢t~km~ ~orm<m ,ate. Stenm~ rate as we, as pnx:e~r~ 
dumlian and su~mms me influenoed by a learning ctmre. ~mo to admissmn 
iS the most pmdiclive f~"tor Of n'ol~ity. 
i02~is21 oimmm~s in pau~t= With ~ aWr.ard~= 
' ' !nfatrcUon Treated Wlth PHmary .~HmOiopia.My Or 
Thmmbo~/t!¢ Therapy? 
R. Zahn ~ , S. Schustm ~ , R Sch~e~, G. Berg ~, 1". Vo~gti~xleP, M. Gottwi~, 
J. Senges ~ . F~r de MIrRA Studien Gmppe, G~many: ~ Ludwigshaten, 
G ~  a~j ,  Germany; :~Mair~, Gen'nany: +Numberg, Germany 
Background: Prtma~ angmplasty (PA) is an alternative to thrombetys~s (TL) 
in the tmwment of acute myec~rdlal infarclJon (AMI). Howe~er liffie is known 
abOUt he differences in clinical pre.ctice in patients (pts) with AMI treated with 
one oHhe two therapies. 
Methods and Results: 5869 pts with AMI were registered by the MITRA 
study. 477 (8.196) pts were treated with PA and 2810 (47.9%) pts with TL 
Pts treated with PA were younger and had had higher rate of previous MI 
(19% vs. t5.2%, p .= 0.039). Pre-hosp,lal delay time was longer in the PA 
grOup (161 vS. 120 minutes, p = 0.001) as wall as door to treatment brae 
(85 vs. 30 minutes; p = 0.001). Pts lreated w~th PA received more often 
F-blockers (64.~+ vs. 58.1%, p = 0.008), hep~n (98.1% vs. 91.4%, p = 
0.001), ACE inhibitors (63~9% vS. 50%, p = 0.001) and the so called "optimal" 
medication (55.6% vs. 43, p = 0.001). There was a reduction in the incidence 
of heart failure for pts treated with PA (5.5% vs. 16.4%, p = 0.00 t ), post infarct 
angina (7.1% vs. 16.3.°.o, p = 0.001) and in-hospilal death (8% vs. 11.7%, p 
= 0.017). However multivariate anaiys~s revealed only "optimal" concomitant 
medication (OR = 0.77, p = 0.0001), but not the type of mvasculanzation 
(0.85, p = 0.1013) to be associated with a signifmant reduction in the death 
rate. 
Conclusions: In clinical practice ptS treated with PA receive more often 
/+-blockers and ACE inhibitors, which Contribute tO a great pad to the overall 
reduction in mortality, overt head failure and post infarct angina in these pts 
as compared to pts treated with TL 
[ 1029'i 531 Early Angloplasty in Acute Myocardial 
Infarction: Angiographic and Clinical Outcome 
in 1179 Patients 
F.W. Bar, R. Aalbregt, K. Neven, J, Frederiks, A.J. Oude Ophuis, H.B. de 
Swart, J. Valner, HJ.J. Wellens. Department of Cardiology, University 
Hospital Maastrichf, Maasfficht, The Netherlands 
Background: Angiogmphic and clinical outcome tn 1179 consecutive pa- 
tients with acute myocardial infarction (AMI) were analyzed. These patients 
were all admitted to the University Hospital Maastricht over a 10 year period 
(1986-1997). Since 1992, apart from patients primarily admitted to this hospi- 
tal also patients were sent by surrounding hospitals, 487 Patients had rescue 
angiuplasty (RA) and 692 patients had primary angioplasty (PA). Nearly all 
patients had the intervention within 90 minutes after admission. In patients 
where thrombotysis was given, rescue PTCA was performed if this therapy 
did not reperfuse the artery within 60-75 minutes. 
ABSTRACTS ~ Po~tcr 95A 
ReSults: Basolin~ elate were compar~ I~tw~,n RA and PA A~ ot 
I~ti@nls mc(~sod in time: from 57 y~r~ up t0 1992 to 61 yews ~in¢~ I 
PWenoy rates of RA and PA were s,miter: 88%, Patot~ =~tcn~lj~t trom 86% 
inltiatty to 90%, probably ~g~ to tl~ use of =lent~, Inq~os~l ¢o~t!~ 
wera n4~rly simdar lot RA M~ PA v~th sthckwlg low ~! I ty  (3,7%), 0~ 
~PPTCA W~li mo~ fft~u~lt in FIA (11% v~ 7%; p ~ 0,0~), Ot~ ~ ogCon~ 
we~ ~ (ovmalt mo~tdity 5,8%)./~ain, no m~ ~tfw¢~¢~ m k~l  ~rm 
flint yea~ a~r AMI w~m ~ og~, left mare ~t~ ocdu~,o~, f~ l~ ~io~ 
and inl~p~ ize, 
Conc/u~m; Eady Img io~ty  in AMI ~ultC, d in r~t~,cy r~ of S~. 
~n¢l low m.ho~pit~l mortality (~,7%), Ogt¢@~ of RA ~d PA w~ c0ml~r~ 
in th~ l~r~t y~r alter AML 
Late Outcome= of PoMInfarctlon Therapkll 
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[ 103~i251 The l.flu~n~ t Thrombolytlc Tlmmpy =n the 
..... Lon~plerm Pn~l i¢~ Vl~llJ~ of  Exer(:ise Tnt lng  
Infar,~lon 
L. At~ou~, J. H~r, I. Emen, W. ~ ~ M~al  Center. 
TechtuO~, Hails, Ist;~et 
Back~-  The USefulness of po~formlng exercise testing (ET) ~dy after 
acWe m y ~  infamtion (AMI) for pr~;~ting the Ioeg-term pr0gn~Js in 
patients treated in the ttm~nboly1~c era ~ not t~en estal~lisl~ed. 
Methods: 446 consecutive IPatierrts (pts) ~i~¢'h@rl~ from or~ CoronaP/ 
Care Unit and etigib~e for ET 3 weeks_ post-AMl were evalu~ale~ prospect~ely 
and followed for 6 years. 263 pts received thm~is  and 183 ~d not- The 
2 groups w~e not randomized and had different baseline cbera~enst~cS. 
Results: In pa~ts  receNmg thrombely=s subsequent cardiac de~th was 
related to diabetss bu1 to no ET-re Wed parameter ~i multivanate analysis. 
Recurrent AMI could not be related tO any parameter 5hJdied. Need for 
revascularization was misted to post-infarctmn an~na, use of calcium an- 
tagonists and >_2 mm ST-T segment depression dunog ET. In palzentS not 
rece~ thromboI,F,~s, cardiac death was related 1o reduced left ventnCular 
funcbon at discharge and 2 ET.related parameterS: low functional capacity 
and _>2 mm ST-T segment depression. Recurrent AMI was not predicted by 
any vanable studied. Need for revasculanzation was related to low Norris 
Index, non-stunk.rag status, use ot bela-bloCkers, calcaum a~'~tagortl~ts and 
post-mfarcl~on a gina. 
Conclusion: In a population treated by thmml3olysis for AMI. ET-parame- 
ters measured 3 weeks post-AMI have little value for predict,ng supplement 
~ l  events during a 6-years follow,up period. ET-mlated parameters cor- 
related signifmantly with the per/ormance af subsequent revascularization 
procedures. In the population no1 treated with thmmbolysis, ET<tsnved pa- 
remeters were signircanfty correlated w~th cardiac ~eath but not to recurrent 
AML 
I 1030-1261 NO Reflow Phenomenon as a Predictor of  
t - '~  COmplications in the Chronic Stage of 
Reperfusecl Acute Myocardial Infarction 
K. Sugimoto, H. [tO, K Iwakura, N Nishikawa, K. Hiraoka. Y. Higashino, 
K. Fuid. Sa.=cu.,abashi Watanabe Hospital, Osaka, Japan 
Background: We previously reported that no inflow phenomenon at cOronan/ 
reflow can discnminate those with poor functional and ctinical outcomes 
during hospitalization from those with favorable outcomes, In this study, we 
invest=gated whether this phenomenon can also predict clinical outcomes 
and LV mmodedng in the chronic stage of AMI 
Methods: We performed myocardial contrast echocardiegraphy (MCE) in 
the 83 patients with an anterior wall AMI after PTCA. We performed 2-D 
echocardiography atday-1 and 3 months later to determine the end-diastolic 
LV ~iameter (LVDd). We ~so assessed clinical events such as heart failure, 
malignant arrhythmiaso coronary interventzon and cardiac death nuring the 
follow up penod (32.2 ± 16.1 months). 
Results: MCE no reflow was observed in 41 patients (Group 11. while 
the other 42 patients manifested MCE inflow (Group 2). LVDd signicantly 
increased from day-1 to 3 months later in Group 1 (54 ± 4 to 56 - 5 rnm 
p < 0.05) but not in Group 2. We observed heart failure in four patients and 
cardiac death in six pat(ents in Group 1 but in none of Group 2 (p < 0.05). 
There were nO dilferences in the incidence of malignant arrhythmias and 
coronary intervention between two groups. 
96A ABSTR, AC['S - Poster JACC Februa~ 1998 
Cone~us~on: MCE no reflow can discriminate individual patients with the 
high risk of progressive LV remodeling, heart failure and cardiac death from 
those with fav0rahlo outcomes even in the chronic stage el AMI, 
~ Evlden©e for Advoree Interaction Botwean on 
ACE Inhlbltora and Aspirin Following Myocardial 
InfarCtion: The GUSTO.I Trial 
J,G, Paterson, Me, k~uer, J,B, Youn0, S, Sapp, R,M, CaUIf, E,J, Topoi, 
Cleveland Clinic Found~lflOn, Cleveland, OH,/~nd O¢lke Univer~ity, O~rtttlm. 
N¢, USA 
B~ek~round: A~ptrln ha~ been shown to redu0o 10nil-term mort,~llty ~ffer 
a(~ute myocar0ial tnforotion (MI); ~ngiotenstn converting enzyme inhlbitore 
(ACE.I) are al~o ellen used offer MI, There i~ concern thai tlt0~o two 0gents 
may edvor~01y Inforset wllh one another; the Impa~t Of this interaction among 
p_~tl~nls wlfhocd heart latium h~s not boon ~Amfully examined, 
M(}thods: Consecullve MI patients who ro¢otved thromb01ysls at~ part el 
the GUSTO-I trial, who survived o( lea~t 30 d~tys, end who did not d0volop 
heoJrt failure (n ,~ 31,3~8) word studied. Medications el lime of hospital 
discharge were holed, The primary ondpotnt w~ ~ll.o~o~o mortality BI one 
y~ar 
EfO~ttlt~: During follow.~Jp there wore 615 ds~th~ Aspirin was proscribed 
lot I;10% 0l patients, of whom 15% ~leo rsoolved AGE.I, Use of ospinn alone 
w~s associated Will~ reduced mort~tlity (Kaplan.Molor rates 1.7% vt~. 3,7%, 
P • 0,001); I~ewOver, wh0n ACE.I woto concorrontly used, ~sp~r*n was not 
~8~0¢latt~d with reduced morlality (3,5% w, 3,7%, P -- 0,B), After ~dlusting 
lot ~go, gender, treatment, Infarct location, ~nd other ¢onloundors, aspirin 
rem~lns~.l associated with reduced mortality (rslallve risk [RR] 0,43, 05% CI 
0,31,.-0,61, P -. 0,0001); however, AC~.I use haq an adverse Intoraell0n with 
aspirin (adjusted RR for use of both agents a.31, 95% CI 1.17-4,59, P = 
0.02). 
Concll+$ton: Among MI survivors without heart failure, the use OI ACE-I 
after thrombolysi8 may reduce th~ mortality benefit at~sociatod with ~lr~pmn. 
This potentially Important drug Interaction wartant~ further study, 
~28~ Effect of Pro longed Captoprll Versus 
NltrOglycerln Therapy on DlaMoll¢ Dysfunct ion 
After Trensmural Myocardlal Infarction 
M. Balghlth, V, Meade, O.P. Human, B,I, dugdutt UniversttyotAlberta, 
~dmonton. AlOerta, Canada 
BackgrOund: limitation of remodeling with angiolonsin-converting enzyme 
(ACE) inhlbitors after tmnsmur~l acute myocardial infarction (TAMI) is as. 
sociated with improved systolic function, The effects of the ACE inhibitor 
captopril (CL) and nitroglycerin (NTG) on diastolic dysfunction have not been 
compared 
Methods: Quantitahve two-d*mensional echocardiograms and Doppler el 
t 60 patients, who wore randomized (double.blind f~ctorlat design, n = 20/cell) 
48 hours after a first anterior (ATAMi) or intoner (ITAMI) TAMI to placebo, 
CL (6.25-25 mg TID), NTG (buccal t-..3 mg TID; 5 t~ourly with an B-hour 
washout) or NTG + CL for 6 w0oks, wore analyzed for peak early (E) and 
late (A) Ilow velocity, E/A ratio and deceleration time (DT) as well as other 
remodeling parameters at 4 intentals (2 days, 6 weeks, 6 months, 1 year). 
Results: Pement changes over 1 year (mean ± SEM) were: 
Placebo CL NTG NTG + CL 
ATAMI 
E/A ratio tOt9 20~6" 22 ~: 17 28 t: 16 
DT S8 • 13 20 t 9" 39 L 17 36 :L 14 
ITAMI 
~A+alia -6 ~ tS 6 ~ 16 30 t 17 22 * 16 
DT 1 .+ 13 13 ± 7 18 ~ 15 3 ~ 8 
P O 009verSus Placebo {ANOVA) 
COnclusion: Persistent improvement in diastolic function WaS only signifi- 
cant in the ATAMI subgroup receiving Caplopril therapy. 
• Effect Of Beta Blockade on Mortality in Patients 
With Contralndicatlons Post Myocardial 
Infarction 
S.S, Gottlieb, R. McCarter, R. Vogel. University of Maryland School of 
Medicine, Baltimore. MD. USA 
The value el /~-blockers following myocardial infarction (MI) is well docu- 
mented, However, CHF, COPD, left ventricular dysfunction (EF <40). dia- 
betes (DM) & older age are often considered centraindications for their use. 
The impact of tbblockers in pts receiving other medications, such as throm- 
bolytics (Lytics) or ACE inhibitors (ACE) also has not been tested, We used 
CooporaUve Cardiovascular Project data to delineate which patients benefit 
from #-blockers following a MI. 
In 127,370 pts, we compared mortality in pie given (38%) or not given 
(62%) p.bloekors on hospital dlscl}argo, Cox regression meddle were used 
to compare Ihe 3 year survival rates (median 23 months). The m~ls  
accounted for dllfemntlel follow-up and controlled COml~flsons for ~k~mo. 
graphic, physiologic, and comorbld factors. The total mortality (%) ar~ a~ 
lusted risk reduction (RR, %) Is given, 
. . . . . . .  _c~_,  +__~o~ ............ +.~+.:7~ ....... e_ ~::~_0_____°~ .......... uv,~+ A~ 
Mo~l ~?,0 4t.1 4~.~ 4~t,~ ~,7 t~,t ~,9 
Mortality, which ~veragod 9~%, was reduced by 30% in lh~ on pJ~lock_m's, 
/I.blockada was assogi~ted with lower mortality in all ~ul~lroUl~ ot Ip~fieN~, 
Race, age, salt, COPD, ej~llon ft~t;Uon, DM, Lyrics, AC!~, & ol~r a gt~ ~id 
net affeo! RR A hlsten/ol CHF deomased RR, but I~qa~so el the high 
mortality rate, obsolete benefit wi~ similar, 
Them am andoubtodly p~ients In whom #,blecker~ shonld not ~ given, 
However, c~ntrolling for in~li~s 0f di~ea~ severity 8e~ motta!ity n~k, I~t~nl~ 
post MI normally considered to h~ve ~ntrt~in~i~tion~ had l~Itter ~ur~iv~! 
when giwn tl.bl~kem, These data sqggeat th~l #.blocker's hOg!d b@ give1 
t0 pOSt MI pati6nts whenever possible, 
• Different Outcome of  I~t ient~ With SuMalnad 
Monomorphio VantriGuler To©hyc~rdio R~llu!ring 
Cardiovorllon During A©uW M~rt l i I I  
Infarction: Analysis in the GUSTO I Study 
A Natalo, 1". Thompson, E Sga~O.~, G. Wagner, A. I]a~agelata, 
E. Topoi, R. Califf, For the GUSTO investigators, Univ~trsity of K~ntucky 
Lexington, KY: Duke Universi~ Outham, NC, US4 
In the GUSTO I population we analyzed the outcome of patients experiencing 
sustained monomqlphie ventricqlar taehyca~ia (VT) during hospital~zat~. 
Of the 40,895 patients enrolled in the study 1439 (3,5%) I~d sustained 
monomo~hic ventncular tachyca~ia, Age. previous MI. Killip Class, antenor 
MI, and depressed ej~tion hactiun wOru ~l~.,',',',',',',',','~i~t~-'vl with ~ higher ri~k of 
sustained VT. In-hOspital and 30 day mortality rate were higher in the VT 
group (p < 0.001 ). When patients with VT were divided in those who dig (452 
patients) and, did not (983 patients) required electrical cardiovetsion, the 
former group Showed an increased in.hospital mort~dity (35% vs. 11.1%, p < 
0.001). Similarly, the 1 year mortality of 30 day survzvorS was higher in the 
group receiving cardiovorsion (11.3% vs. 5.8%, p = 0.003). However. both the 
cardioversion and no eardioverslon groups had higl'er I year mo~tat,ly ~ate 
than the group without ventncular arrhythmias. In patients with VT tequmng 
cardioversion in-hospital, and t year mortality remained higher than the 
no-arrhythmia group even when analysis was pertotmed ividing the patients 
in those with early (<2 days} and late (>2 days) occunence of sustained 
VT (p -. 0,001). In conclusion among Patients experiencing sustained VT 
during acute MI the need for cardiove.sion identified a subgroup w*th higher 
in-hospital, 1 year mortality regardless of the early or late occurrence Of this 
arrhythmia. 
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I1 -1 I Are Physicians any Better Prepared Than 031 31 
DenUst~ for an Off ice Cardiac Emergency? 
J, P. ornate, MA. Peberdy, J. Campbell, R, Campbell, R. Flank, 
C.J, SchmeiL A. Heffner, P. Kamilakis. Virginia Commonwealth 
University~Medical College of Virginia, Richmond. Virginia, USA 
To determine whether physicians are better prepared than dentists for an 
office cardiac emergency, we randomly surveyed 51 primanj care physi- 
cians (MDs~ and 224 dentists (DDSs) in Richmond, VA. DDSs performed 
conscious sedation (45% vs 4%, p < 0.000001), local (99% vs. 55%, p < 
0.000001) and general anesthesia (8% vs 0%, p < 0.04) more often than 
MDs. More DDSs had oxygen (96% vs. 78%, p < 0.000001) but less often 
had Iv equipment (23% vs 51%, p < 0.00007) than MDs. Although the rate 
of emergencies/100.000 pt visits requiring interventions (CPR, Ambu bag. 
intubation, defibrillation, or drug therapy) was higher in MD vs DDS Offices 
(39% vs 11%, p = 0.006), there were no differences in the % of MD vs 
DDS offices containing an Ambu bag (82% vs 79%, p = 0.59), intubation 
equipment (53% vs 40%, p = 0.10), epinephrine (92% vs 89%, p = 0.49), 
